{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:56:20Z","timestamp":1793926580335,"version":"4.8.0"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T00:00:00Z","timestamp":1522627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s12035-018-1016-x","type":"journal-article","created":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T18:23:24Z","timestamp":1522693404000},"page":"8885-8903","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":296,"title":["The Compensatory Immune-Regulatory Reflex System (CIRS) in Depression and Bipolar Disorder"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2012-871X","authenticated-orcid":false,"given":"Michael","family":"Maes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre F.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,2]]},"reference":[{"issue":"5","key":"1016_CR1","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1001\/archpsyc.1984.01790160070008","volume":"41","author":"SJ Schleifer","year":"1984","unstructured":"Schleifer SJ, Keller SE, Meyerson AT, Raskin MJ, Davis KL, Stein M (1984) Lymphocyte function in major depressive disorder. Arch Gen Psychiatry 41(5):484\u2013486","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"1016_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0165-1781(87)90010-2","volume":"20","author":"M Irwin","year":"1987","unstructured":"Irwin M, Gillin JC (1987) Impaired natural killer cell activity among depressed patients. Psychiatry Res 20(2):181\u2013182","journal-title":"Psychiatry Res"},{"key":"1016_CR3","volume-title":"In: Immunology","author":"IM Roitt","year":"1985","unstructured":"Roitt IM, Brostoff J, Male DK (1985) In: Immunology. Gower Medical Publishing, New York"},{"key":"1016_CR4","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1192\/bjp.155.6.793","volume":"155","author":"M Maes","year":"1989","unstructured":"Maes M, Bosmans E, Suy E, Minner B, Raus J (1989) Impaired lymphocyte stimulation by mitogens in severely depressed patients. A complex interface with HPA-axis hyperfunction, noradrenergic activity and the ageing process. Br J Psychiatry 155:793\u2013798","journal-title":"Br J Psychiatry"},{"issue":"4","key":"1016_CR5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1600-0447.1991.tb03163.x","volume":"84","author":"M Maes","year":"1991","unstructured":"Maes M, Bosmans E, Suy E, Vandervorst C, DeJonckheere C, Raus J (1991) Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production. Acta Psychiatr Scand 84(4):379\u2013386","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"1016_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0165-1781(00)00216-X","volume":"96","author":"M Maes","year":"2000","unstructured":"Maes M, Lin A, Kenis G, Egyed B, Bosmans E (2000) The effects of noradrenaline and alpha-2 adrenoceptor agents on the production of monocytic products. Psychiatry Res 96(3):245\u2013253","journal-title":"Psychiatry Res"},{"issue":"3","key":"1016_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000119472","volume":"24","author":"M Maes","year":"1990","unstructured":"Maes M, Bosmans E, Suy E, Vandervorst C, De Jonckheere C, Raus J (1990) Immune disturbances during major depression: Upregulated expression of interleukin-2 receptors. Neuropsychobiology 24(3):115\u2013120","journal-title":"Neuropsychobiology"},{"key":"1016_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","volume":"27","author":"CA Dinarello","year":"2009","unstructured":"Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519\u2013550","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"1016_CR9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.bbi.2009.02.015","volume":"23","author":"S Spulber","year":"2009","unstructured":"Spulber S, Bartfai T, Schultzberg M (2009) IL-1\/IL-1ra balance in the brain revisited - evidence from transgenic mouse models. Brain Behav Immun 23(5):573\u2013579","journal-title":"Brain Behav Immun"},{"issue":"5","key":"1016_CR10","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.4049\/jimmunol.135.5.3172","volume":"135","author":"LA Rubin","year":"1985","unstructured":"Rubin LA, Kurman CC, Fritz ME, Biddison WE, Boutin B, Yarchoan R, Nelson DL (1985) Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 135(5):3172\u20133177","journal-title":"J Immunol"},{"issue":"8","key":"1016_CR11","doi-asserted-by":"publisher","first-page":"619","DOI":"10.7326\/0003-4819-113-8-619","volume":"113","author":"LA Rubin","year":"1990","unstructured":"Rubin LA, Nelson DL (1990) The soluble interleukin-2 receptor: Biology, function, and clinical application. Ann Intern Med 113(8):619\u2013627","journal-title":"Ann Intern Med"},{"issue":"8","key":"1016_CR12","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1056\/NEJM197208242870806","volume":"287","author":"HN Claman","year":"1972","unstructured":"Claman HN (1972) Corticosteroids and lymphoid cells. N Engl J Med 287(8):388\u2013397","journal-title":"N Engl J Med"},{"issue":"1","key":"1016_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/0008-8749(83)90344-1","volume":"76","author":"FO Ranelletti","year":"1983","unstructured":"Ranelletti FO, Musiani P, Maggiano N, Lauriola L, Piantelli M (1983) Modulation of glucocorticoid inhibitory action on human lymphocyte mitogenesis: Dependence on mitogen concentration and T-cell maturity. Cell Immunol 76(1):22\u201328","journal-title":"Cell Immunol"},{"issue":"3","key":"1016_CR14","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/0090-1229(88)90032-3","volume":"48","author":"E Bloemena","year":"1988","unstructured":"Bloemena E, van Oers MH, Weinreich S, Yong SL, Schellekens PT (1988) Prednisolone and cyclosporin a exert differential inhibitory effects on T-cell proliferation in vitro. Clin Immunol Immunopathol 48(3):380\u2013391","journal-title":"Clin Immunol Immunopathol"},{"issue":"1","key":"1016_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0278-5846(94)00101-M","volume":"19","author":"M Maes","year":"1995","unstructured":"Maes M (1995) Evidence for an immune response in major depression: A review and hypothesis. Prog Neuro-Psychopharmacol Biol Psychiatry 19(1):11\u201338","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"4","key":"1016_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0165-0327(95)00028-L","volume":"34","author":"M Maes","year":"1995","unstructured":"Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R (1995) Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 34(4):301\u2013309","journal-title":"J Affect Disord"},{"issue":"2","key":"1016_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0022-3956(94)00049-W","volume":"29","author":"M Maes","year":"1995","unstructured":"Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY (1995) Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptics and mood stabilizers. J Psychiatr Res 29(2):141\u2013152","journal-title":"J Psychiatr Res"},{"issue":"3","key":"1016_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0924-977X(01)00081-5","volume":"11","author":"O Mikova","year":"2001","unstructured":"Mikova O, Yakimova R, Bosmans E, Kenis G, Maes M (2001) Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis. Eur Neuropsychopharmacol 11(3):203\u2013208","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"1016_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","volume":"71","author":"MB Howren","year":"2009","unstructured":"Howren MB, Lamkin DM, Suls J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. Psychosom Med 71(2):171\u2013186","journal-title":"Psychosom Med"},{"issue":"5","key":"1016_CR20","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanct\u00f4t KL (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67(5):446\u2013457","journal-title":"Biol Psychiatry"},{"issue":"3","key":"1016_CR21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jad.2011.08.003","volume":"139","author":"Y Liu","year":"2012","unstructured":"Liu Y, Ho RC, Mak A (2012) Interleukin (IL)-6, tumour necrosis factor alpha (TNF-\u03b1) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression. J Affect Disord 139(3):230\u2013239","journal-title":"J Affect Disord"},{"issue":"10","key":"1016_CR22","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1017\/S0033291712000128","volume":"42","author":"SA Hiles","year":"2012","unstructured":"Hiles SA, Baker AL, de Malmanche T, Attia J (2012) Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: A meta-analysis. Psychol Med 42(10):2015\u20132026","journal-title":"Psychol Med"},{"issue":"3","key":"1016_CR23","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jad.2013.06.004","volume":"150","author":"V Valkanova","year":"2013","unstructured":"Valkanova V, Ebmeier KP, Allan CL (2013) CRP, IL-6 and depression: A systematic review and meta-analysis of longitudinal studies. J Affect Disord 150(3):736\u2013744","journal-title":"J Affect Disord"},{"key":"1016_CR24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","volume":"49","author":"R Haapakoski","year":"2015","unstructured":"Haapakoski R, Mathieu J, Ebmeier KP, Alenius H, Kivim\u00e4ki M (2015) Cumulative meta-analysis of interleukins 6 and 1\u03b2, tumour necrosis factor \u03b1 and C-reactive protein in patients with major depressive disorder. Brain Behav Immun 49:206\u2013215","journal-title":"Brain Behav Immun"},{"key":"1016_CR25","doi-asserted-by":"publisher","unstructured":"K\u00f6hler CA, Freitas TH, Stubbs B, Maes M, Solmi M, Veronese N, de Andrade NQ, Morris G, Fernandes BS, Brunoni AR, Herrmann N, Raison CL, Miller BJ, Lanct\u00f4t KL, Carvalho AF (2017) Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: Systematic review and meta-analysis. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-017-0632-1","DOI":"10.1007\/s12035-017-0632-1"},{"issue":"5","key":"1016_CR26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/acps.12698","volume":"135","author":"CA K\u00f6hler","year":"2017","unstructured":"K\u00f6hler CA, Freitas TH, Maes M, de Andrade NQ, Liu CS, Fernandes BS, Stubbs B, Solmi M et al (2017) Peripheral cytokine and chemokine alterations in depression: A meta-analysis of 82 studies. Acta Psychiatr Scand 135(5):373\u2013387","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"1016_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.biopsych.2013.01.007","volume":"74","author":"A Modabbernia","year":"2013","unstructured":"Modabbernia A, Taslimi S, Brietzke E, Ashrafi M (2013) Cytokine alterations in bipolar disorder: A meta-analysis of 30 studies. Biol Psychiatry 74(1):15\u201325","journal-title":"Biol Psychiatry"},{"issue":"9","key":"1016_CR28","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","volume":"47","author":"K Munkholm","year":"2013","unstructured":"Munkholm K, Bra\u00fcner JV, Kessing LV, Vinberg M (2013) Cytokines in bipolar disorder vs. healthy control subjects: A systematic review and meta-analysis. J Psychiatr Res 47(9):1119\u20131133","journal-title":"J Psychiatr Res"},{"key":"1016_CR29","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1741-7015-10-66","volume":"10","author":"M Maes","year":"2012","unstructured":"Maes M, Berk M, Goehler L, Song C, Anderson G, Ga\u0142ecki P, Leonard B (2012) Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med 10:66","journal-title":"BMC Med"},{"issue":"4","key":"1016_CR30","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ccm.2008.06.010","volume":"29","author":"NS Ward","year":"2008","unstructured":"Ward NS, Casserly B, Ayala A (2008) The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients. Clin Chest Med 29(4):617\u2013625 viii","journal-title":"Clin Chest Med"},{"issue":"7","key":"1016_CR31","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1097\/00003246-199607000-00010","volume":"24","author":"RC Bone","year":"1996","unstructured":"Bone RC (1996) Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 24(7):1125\u20131128","journal-title":"Crit Care Med"},{"issue":"7","key":"1016_CR32","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1097\/01.CCM.0000069345.78884.0F","volume":"31","author":"G Monneret","year":"2003","unstructured":"Monneret G, Debard AL, Venet F, Bohe J, Hequet O, Bienvenu J, Lepape A (2003) Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med 31(7):2068\u20132071","journal-title":"Crit Care Med"},{"issue":"6","key":"1016_CR33","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1084\/jem.20062602","volume":"204","author":"MJ Delano","year":"2007","unstructured":"Delano MJ, Scumpia PO, Weinstein JS, Coco D, Nagaraj S, Kelly-Scumpia KM, O'Malley KA, Wynn JL et al (2007) MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med 204(6):1463\u20131474","journal-title":"J Exp Med"},{"issue":"5","key":"1016_CR34","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1084\/jem.174.5.1209","volume":"174","author":"R Waal Malefyt de","year":"1991","unstructured":"de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE (1991) Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174(5):1209\u20131220","journal-title":"J Exp Med"},{"issue":"Suppl 1","key":"1016_CR35","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1097\/00024382-199606001-00007","volume":"6","author":"A Ayala","year":"1996","unstructured":"Ayala A, Chaudry IH (1996) Immune dysfunction in murine polymicrobial sepsis: Mediators, macrophages, lymphocytes and apoptosis. Shock 6(Suppl 1):S27\u2013S38","journal-title":"Shock"},{"issue":"6","key":"1016_CR36","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1097\/TA.0b013e318256e000","volume":"72","author":"LF Gentile","year":"2012","unstructured":"Gentile LF, Cuenca AG, Efron PA, Ang D, Bihorac A, McKinley BA, Moldawer LL, Moore FA (2012) Persistent inflammation and immunosuppression: A common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg 72(6):1491\u20131501","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"1016_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/TA.0b013e3182ab1ab5","volume":"76","author":"EL Vanzant","year":"2014","unstructured":"Vanzant EL, Lopez CM, Ozrazgat-Baslanti T, Ungaro R, Davis R, Cuenca AG, Gentile LF, Nacionales DC et al (2014) Persistent inflammation, immunosuppression, and catabolism syndrome after severe blunt trauma. J Trauma Acute Care Surg 76(1):21\u201329; discussion 29-30","journal-title":"J Trauma Acute Care Surg"},{"key":"1016_CR38","unstructured":"Rosenthal MD, Moore FA (2015) Persistent inflammatory, immunosuppressed, catabolic syndrome (PICS): A new phenotype of multiple organ failure. J Adv Nutr Hum Metab 1(1). e784."},{"issue":"1","key":"1016_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0165-0327(91)90032-N","volume":"23","author":"M Maes","year":"1991","unstructured":"Maes M, Vandewoude M, Scharp\u00e9 S, De Clercq L, Stevens W, Lepoutre L, Schotte C (1991) Anthropometric and biochemical assessment of the nutritional state in depression: Evidence for lower visceral protein plasma levels in depression. J Affect Disord 23(1):25\u201333","journal-title":"J Affect Disord"},{"issue":"3","key":"1016_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0165-0327(92)90066-F","volume":"24","author":"M Maes","year":"1992","unstructured":"Maes M, Scharp\u00e9 S, Van Grootel L, Uyttenbroeck W, Cooreman W, Cosyns P, Suy E (1992) Higher alpha 1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: Further evidence for the existence of an inflammatory response during that illness. J Affect Disord 24(3):183\u2013192","journal-title":"J Affect Disord"},{"issue":"1","key":"1016_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0165-0327(94)00106-J","volume":"34","author":"M Maes","year":"1995","unstructured":"Maes M, Wauters A, Neels H, Scharp\u00e9 S, Van Gastel A, D'Hondt P, Peeters D, Cosyns P et al (1995) Total serum protein and serum protein fractions in depression: Relationships to depressive symptoms and glucocorticoid activity. J Affect Disord 34(1):61\u201369","journal-title":"J Affect Disord"},{"key":"1016_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.12703\/P6-13","volume":"6","author":"FO Martinez","year":"2014","unstructured":"Martinez FO, Gordon S (2014) The M1 and M2 paradigm of macrophage activation: Time for reassessment. F1000Prime Rep 6:13","journal-title":"F1000Prime Rep"},{"issue":"11","key":"1016_CR43","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1517\/14728222.2012.718331","volume":"16","author":"M Maes","year":"2012","unstructured":"Maes M, Song C, Yirmiya R (2012) Targeting IL-1 in depression. Expert Opin Ther Targets 16(11):1097\u20131112","journal-title":"Expert Opin Ther Targets"},{"issue":"Suppl 1","key":"1016_CR44","doi-asserted-by":"publisher","first-page":"i60","DOI":"10.1136\/ard.59.suppl_1.i60","volume":"59","author":"WP Arend","year":"2000","unstructured":"Arend WP, Guthridge CJ (2000) Biological role of interleukin 1 receptor antagonist isoforms. Ann Rheum Dis 59(Suppl 1):i60\u2013i64","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"1016_CR45","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/S0006-3223(99)00211-5","volume":"46","author":"H Anisman","year":"1999","unstructured":"Anisman H, Ravindran AV, Griffiths J, Merali Z (1999) Interleukin-1 beta production in dysthymia before and after pharmacotherapy. Biol Psychiatry 46(12):1649\u20131655","journal-title":"Biol Psychiatry"},{"issue":"4","key":"1016_CR46","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3109\/15622970802573246","volume":"10","author":"JE Piletz","year":"2009","unstructured":"Piletz JE, Halaris A, Iqbal O, Hoppensteadt D, Fareed J, Zhu H, Sinacore J, Devane CL (2009) Pro-inflammatory biomakers in depression: Treatment with venlafaxine. World J Biol Psychiatry 10(4):313\u2013323","journal-title":"World J Biol Psychiatry"},{"issue":"2","key":"1016_CR47","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/JGP.0b013e3181c2947f","volume":"18","author":"BS Diniz","year":"2010","unstructured":"Diniz BS, Teixeira AL, Talib L, Gattaz WF, Forlenza OV (2010) Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients. Am J Geriatr Psychiatry 18(2):172\u2013176","journal-title":"Am J Geriatr Psychiatry"},{"issue":"2","key":"1016_CR48","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1177\/1099800408323220","volume":"10","author":"EJ Corwin","year":"2008","unstructured":"Corwin EJ, Johnston N, Pugh L (2008) Symptoms of postpartum depression associated with elevated levels of interleukin-1 beta during the first month postpartum. Biol Res Nurs 10(2):128\u2013133","journal-title":"Biol Res Nurs"},{"issue":"1","key":"1016_CR49","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.pnpbp.2011.09.006","volume":"36","author":"M Maes","year":"2012","unstructured":"Maes M, Mihaylova I, Kubera M, Ringel K (2012) Activation of cell-mediated immunity in depression: Association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression. Prog Neuro-Psychopharmacol Biol Psychiatry 36(1):169\u2013175","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"1\u20132","key":"1016_CR50","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0165-0327(95)00049-6","volume":"36","author":"M Maes","year":"1995","unstructured":"Maes M, Vandoolaeghe E, Ranjan R, Bosmans E, Bergmans R, Desnyder R (1995) Increased serum interleukin-1-receptor-antagonist concentrations in major depression. J Affect Disord 36(1\u20132):29\u201336","journal-title":"J Affect Disord"},{"issue":"11","key":"1016_CR51","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1006\/cyto.1997.0238","volume":"9","author":"M Maes","year":"1997","unstructured":"Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H (1997) Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9(11):853\u2013858","journal-title":"Cytokine"},{"issue":"2","key":"1016_CR52","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s12640-017-9835-5","volume":"33","author":"Magdalena Sowa-Ku\u0107ma","year":"2017","unstructured":"Sowa-Ku\u0107ma M, Stycze\u0144 K, Siwek M, Misztak P, Nowak RJ, Dudek D, Rybakowski JK, Nowak G, Maes M (2017) Lipid peroxidation and immune biomarkers are associated with major depression and its phenotypes, including treatment-resistant depression and melancholia. Neurotox res. Nov 4. https:\/\/doi.org\/10.1007\/s12640-017-9835-5","journal-title":"Neurotoxicity Research"},{"key":"1016_CR53","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.pnpbp.2017.08.024","volume":"81","author":"M Sowa-Ku\u0107ma","year":"2018","unstructured":"Sowa-Ku\u0107ma M, Stycze\u0144 K, Siwek M, Misztak P, Nowak RJ, Dudek D, Rybakowski JK, Nowak G et al (2018) Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: Effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts. Prog Neuro-Psychopharmacol Biol Psychiatry 81:372\u2013383","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"4","key":"1016_CR54","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000026615","volume":"40","author":"J Levine","year":"1999","unstructured":"Levine J, Barak Y, Chengappa KN, Rapoport A, Rebey M, Barak V (1999) Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 40(4):171\u2013176","journal-title":"Neuropsychobiology"},{"issue":"7","key":"1016_CR55","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/bdi.12214","volume":"16","author":"X Monfrim","year":"2014","unstructured":"Monfrim X, Gazal M, De Leon PB, Quevedo L, Souza LD, Jansen K, Oses JP, Pinheiro RT et al (2014) Immune dysfunction in bipolar disorder and suicide risk: Is there an association between peripheral corticotropin-releasing hormone and interleukin-1\u03b2? Bipolar Disord 16(7):741\u2013747","journal-title":"Bipolar Disord"},{"issue":"8","key":"1016_CR56","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/bdi.12240","volume":"16","author":"SY Tsai","year":"2014","unstructured":"Tsai SY, Chung KH, Huang SH, Chen PH, Lee HC, Kuo CJ (2014) Persistent inflammation and its relationship to leptin and insulin in phases of bipolar disorder from acute depression to full remission. Bipolar Disord 16(8):800\u2013808","journal-title":"Bipolar Disord"},{"issue":"6","key":"1016_CR57","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/bdi.12320","volume":"17","author":"GN Pandey","year":"2015","unstructured":"Pandey GN, Ren X, Rizavi HS, Zhang H (2015) Abnormal gene expression of proinflammatory cytokines and their receptors in the lymphocytes of patients with bipolar disorder. Bipolar Disord 17(6):636\u2013644","journal-title":"Bipolar Disord"},{"issue":"11","key":"1016_CR58","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.biopsych.2008.11.011","volume":"65","author":"Y Milaneschi","year":"2009","unstructured":"Milaneschi Y, Corsi AM, Penninx BW, Bandinelli S, Guralnik JM, Ferrucci L (2009) Interleukin-1 receptor antagonist and incident depressive symptoms over 6 years in older persons: The InCHIANTI study. Biol Psychiatry 65(11):973\u2013978","journal-title":"Biol Psychiatry"},{"issue":"3","key":"1016_CR59","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H","volume":"50","author":"HT Idriss","year":"2000","unstructured":"Idriss HT, Naismith JH (2000) TNF alpha and the TNF receptor superfamily: Structure-function relationship(s). Microsc Res Tech 50(3):184\u2013195","journal-title":"Microsc Res Tech"},{"issue":"3\u20134","key":"1016_CR60","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S1359-6101(03)00022-4","volume":"14","author":"K Pfeffer","year":"2003","unstructured":"Pfeffer K (2003) Biological functions of tumor necrosis factor cytokines and their receptors. Cytokine Growth Factor Rev 14(3\u20134):185\u2013191","journal-title":"Cytokine Growth Factor Rev"},{"issue":"4","key":"1016_CR61","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1194\/jlr.R600021-JLR200","volume":"48","author":"C Popa","year":"2007","unstructured":"Popa C, Netea MG, van Riel PL, van der Meer JW, Stalenhoef AF (2007) The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J Lipid Res 48(4):751\u2013762","journal-title":"J Lipid Res"},{"key":"1016_CR62","doi-asserted-by":"publisher","first-page":"861231","DOI":"10.1155\/2014\/861231","volume":"2014","author":"G Olmos","year":"2014","unstructured":"Olmos G, Llad\u00f3 J (2014) Tumor necrosis factor alpha: A link between neuroinflammation and excitotoxicity. Mediat Inflamm 2014:861231","journal-title":"Mediat Inflamm"},{"key":"1016_CR63","first-page":"91","volume-title":"Methods in Molecular Medicine, Vol 36: Septic Shock","author":"MG Bouma","year":"1999","unstructured":"Bouma MG, Buurman WA (1999) Assay of soluble tumor necrosis factor receptors. In: Evans TJ (ed) Methods in Molecular Medicine, Vol 36: Septic Shock. Humana Press Inc., Totowa, pp. 91\u2013100"},{"issue":"3","key":"1016_CR64","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0002-9629(15)40816-X","volume":"320","author":"ZS Huang","year":"2000","unstructured":"Huang ZS, Chiang BL, Hsu KL (2000) Serum level of soluble tumor necrosis factor receptor II (sTNF-R75) is apparently an index of overall monocyte-related infectious and inflammatory activity. Am J Med Sci 320(3):183\u2013187","journal-title":"Am J Med Sci"},{"issue":"1","key":"1016_CR65","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1046\/j.1365-2567.1998.00481.x","volume":"94","author":"CL Selinsky","year":"1998","unstructured":"Selinsky CL, Boroughs KL, Halsey WA Jr, Howell MD (1998) Multifaceted inhibition of anti-tumour immune mechanisms by soluble tumour necrosis factor receptor type I. Immunology 94(1):88\u201393","journal-title":"Immunology"},{"issue":"1","key":"1016_CR66","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/1529-0131(199801)41:1<139::AID-ART17>3.0.CO;2-T","volume":"41","author":"X Su","year":"1998","unstructured":"Su X, Zhou T, Yang P, Edwards CK 3rd, Mountz JD (1998) Reduction of arthritis and pneumonitis in motheaten mice by soluble tumor necrosis factor receptor. Arthritis Rheum 41(1):139\u2013149","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1016_CR67","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000096887","volume":"2","author":"WA Banks","year":"1995","unstructured":"Banks WA, Plotkin SR, Kastin AJ (1995) Permeability of the blood-brain barrier to soluble cytokine receptors. Neuroimmunomodulation 2(3):161\u2013165","journal-title":"Neuroimmunomodulation"},{"issue":"11","key":"1016_CR68","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.1002\/eji.1830211134","volume":"21","author":"W Lesslauer","year":"1991","unstructured":"Lesslauer W, Tabuchi H, Gentz R, Brockhaus M, Schlaeger EJ, Grau G, Piguet PF, Pointaire P et al (1991) Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality. Eur J Immunol 21(11):2883\u20132886","journal-title":"Eur J Immunol"},{"issue":"2","key":"1016_CR69","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00406-010-0116-z","volume":"261","author":"IG Barbosa","year":"2011","unstructured":"Barbosa IG, Huguet RB, Mendon\u00e7a VA, Sousa LP, Neves FS, Bauer ME, Teixeira AL (2011) Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder. Eur Arch Psychiatry Clin Neurosci 261(2):139\u2013143","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"2\u20133","key":"1016_CR70","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jad.2005.11.015","volume":"90","author":"SM O'Brien","year":"2006","unstructured":"O'Brien SM, Scully P, Scott LV, Dinan TG (2006) Cytokine profiles in bipolar affective disorder: Focus on acutely ill patients. J Affect Disord 90(2\u20133):263\u2013267","journal-title":"J Affect Disord"},{"issue":"6","key":"1016_CR71","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/j.1399-5618.2007.00493.x","volume":"9","author":"A Ortiz-Dom\u00ednguez","year":"2007","unstructured":"Ortiz-Dom\u00ednguez A, Hern\u00e1ndez ME, Berlanga C, Guti\u00e9rrez-Mora D, Moreno J, Heinze G, Pav\u00f3n L (2007) Immune variations in bipolar disorder: Phasic differences. Bipolar Disord 9(6):596\u2013602","journal-title":"Bipolar Disord"},{"issue":"3","key":"1016_CR72","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jad.2008.12.001","volume":"116","author":"E Brietzke","year":"2009","unstructured":"Brietzke E, Stertz L, Fernandes BS, Kauer-Sant'anna M, Mascarenhas M, Escosteguy Vargas A, Chies JA, Kapczinski F (2009) Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord 116(3):214\u2013217","journal-title":"J Affect Disord"},{"issue":"8","key":"1016_CR73","doi-asserted-by":"publisher","first-page":"5883","DOI":"10.1007\/s12035-016-0124-8","volume":"54","author":"M Siwek","year":"2017","unstructured":"Siwek M, Sowa-Ku\u0107ma M, Stycze\u0144 K, Misztak P, Nowak RJ, Szewczyk B, Dudek D, Rybakowski JK et al (2017) Associations of serum cytokine receptor levels with melancholia, staging of illness, depressive and manic phases, and severity of depression in bipolar disorder. Mol Neurobiol 54(8):5883\u20135893","journal-title":"Mol Neurobiol"},{"issue":"1","key":"1016_CR74","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1155\/S0962935193000018","volume":"2","author":"C Caruso","year":"1993","unstructured":"Caruso C, Candore G, Cigna D, Colucci AT, Modica MA (1993) Biological significance of soluble IL-2 receptor. Mediat Inflamm 2(1):3\u201321","journal-title":"Mediat Inflamm"},{"issue":"3","key":"1016_CR75","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1155\/MI.2005.121","volume":"2005","author":"AM Witkowska","year":"2005","unstructured":"Witkowska AM (2005) On the role of sIL-2R measurements in rheumatoid arthritis and cancers. Mediat Inflamm 2005(3):121\u2013130","journal-title":"Mediat Inflamm"},{"issue":"3","key":"1016_CR76","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nri3156","volume":"12","author":"O Boyman","year":"2012","unstructured":"Boyman O, Sprent J (2012) The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol 12(3):180\u2013190","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"1016_CR77","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.immuni.2010.08.004","volume":"33","author":"TR Malek","year":"2010","unstructured":"Malek TR, Castro I (2010) Interleukin-2 receptor signaling: At the interface between tolerance and immunity. Immunity 33(2):153\u2013165","journal-title":"Immunity"},{"issue":"12","key":"1016_CR78","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.it.2015.10.003","volume":"36","author":"N Arenas-Ramirez","year":"2015","unstructured":"Arenas-Ramirez N, Woytschak J, Boyman O (2015) Interleukin-2: Biology, design and application. Trends Immunol 36(12):763\u2013777","journal-title":"Trends Immunol"},{"issue":"1","key":"1016_CR79","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/1523-1747.ep12494223","volume":"98","author":"R Dummer","year":"1992","unstructured":"Dummer R, Posseckert G, Nestle F, Witzgall R, Burger M, Becker JC, Sch\u00e4fer E, Wiede J et al (1992) Soluble interleukin-2 receptors inhibit interleukin 2-dependent proliferation and cytotoxicity: Explanation for diminished natural killer cell activity in cutaneous T-cell lymphomas in vivo? J Invest Dermatol 98(1):50\u201354","journal-title":"J Invest Dermatol"},{"key":"1016_CR80","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1182\/blood-2011-03-340885","volume":"118","author":"ZZ Yang","year":"2011","unstructured":"Yang ZZ, Grote DM, Ziesmer SC, Manske MK, Witzig TE, Novak AJ, Ansell SM (2011) Soluble IL-2R\u03b1 facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma. Blood 118:2809\u20132820","journal-title":"Blood"},{"key":"1016_CR81","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1465-9921-12-142","volume":"2","author":"L Yang","year":"2011","unstructured":"Yang L, Ma QL, Yao W, Zhang Q, Chen HP, Wang GS, Wang CZ (2011) Relationship between the anti-inflammatory properties of salmeterol\/fluticasone and the expression of CD4+CD25+Foxp3+ regulatory T cells in COPD. Respir Res 2:142","journal-title":"Respir Res"},{"key":"1016_CR82","first-page":"122","volume":"34","author":"R Vanmaris","year":"2017","unstructured":"Vanmaris R, Rijkers GT (2017) Biological role of the soluble interleukin-2 receptor in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 34:122\u2013129","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"1016_CR83","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1017\/S0033291700032712","volume":"22","author":"M Maes","year":"1992","unstructured":"Maes M, Lambrechts J, Bosmans E, Jacobs J, Suy E, Vandervorst C, de Jonckheere C, Minner B et al (1992) Evidence for a systemic immune activation during depression: Results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychol Med 22(1):45\u201353","journal-title":"Psychol Med"},{"issue":"2","key":"1016_CR84","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0278-5846(93)90045-T","volume":"17","author":"M Maes","year":"1993","unstructured":"Maes M, Stevens WJ, Declerck LS, Bridts CH, Peeters D, Schotte C, Cosyns P (1993) Significantly increased expression of T-cell activation markers (interleukin-2 and HLA-DR) in depression: Further evidence for an inflammatory process during that illness. Prog Neuro-Psychopharmacol Biol Psychiatry 17(2):241\u2013255","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"12","key":"1016_CR85","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/mp.2016.3","volume":"21","author":"DR Goldsmith","year":"2016","unstructured":"Goldsmith DR, Rapaport MH, Miller BJ (2016) A meta-analysis of blood cytokine network alterations in psychiatric patients: Comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry 21(12):1696\u20131709","journal-title":"Mol Psychiatry"},{"issue":"2","key":"1016_CR86","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0165-0327(91)90060-6","volume":"21","author":"M Maes","year":"1991","unstructured":"Maes M, Bosmans E, Suy E, Vandervorst C, Dejonckheere C, Raus J (1991) Antiphospholipid, antinuclear, Epstein-Barr and cytomegalovirus antibodies, and soluble interleukin-2 receptors in depressive patients. J Affect Disord 21(2):133\u2013140","journal-title":"J Affect Disord"},{"issue":"8","key":"1016_CR87","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/0924-9338(96)80345-2","volume":"10","author":"M Maes","year":"1995","unstructured":"Maes M, Bosmans E, Scharp\u00e9 S, D'Hondt P, Desnyder R (1995) Plasma soluble interleukin-2-receptor in depression: Relationships to plasma neopterin and serum IL-2 concentrations and HPA-axis activity. Eur Psychiatry 10(8):397\u2013403","journal-title":"Eur Psychiatry"},{"issue":"1","key":"1016_CR88","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0165-1781(97)00131-5","volume":"77","author":"M Maes","year":"1998","unstructured":"Maes M (1998) Interleukin-2 and schizophrenia. Psychiatry Res 77(1):63\u201364","journal-title":"Psychiatry Res"},{"issue":"5","key":"1016_CR89","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1517\/14728222.2014.888417","volume":"18","author":"M Maes","year":"2014","unstructured":"Maes M, Anderson G, Kubera M, Berk M (2014) Targeting classical IL-6 signalling or IL-6 trans-signalling in depression? Expert Opin Ther Targets 18(5):495\u2013512","journal-title":"Expert Opin Ther Targets"},{"key":"1016_CR90","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neubiorev.2016.02.002","volume":"64","author":"A Slyepchenko","year":"2016","unstructured":"Slyepchenko A, Maes M, K\u00f6hler CA, Anderson G, Quevedo J, Alves GS, Berk M, Fernandes BS et al (2016) T helper 17 cells may drive neuroprogression in major depressive disorder: Proposal of an integrative model. Neurosci Biobehav Rev 64:83\u2013100","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"1016_CR91","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0165-1781(93)90027-E","volume":"49","author":"M Maes","year":"1993","unstructured":"Maes M, Scharp\u00e9 S, Meltzer HY, Bosmans E, Suy E, Calabrese J, Cosyns P (1993) Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res 49(1):11\u201327","journal-title":"Psychiatry Res"},{"issue":"3","key":"1016_CR92","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0165-1781(96)02783-7","volume":"64","author":"A Sluzewska","year":"1996","unstructured":"Sluzewska A, Rybakowski J, Bosmans E, Sobieska M, Berghmans R, Maes M, Wiktorowicz K (1996) Indicators of immune activation in major depression. Psychiatry Res 64(3):161\u2013167","journal-title":"Psychiatry Res"},{"issue":"7","key":"1016_CR93","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S0006-3223(98)00131-0","volume":"45","author":"M Maes","year":"1999","unstructured":"Maes M, Lin AH, Delmeire L, Van Gastel A, Kenis G, De Jongh R, Bosmans E (1999) Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol Psychiatry 45(7):833\u2013839","journal-title":"Biol Psychiatry"},{"issue":"3","key":"1016_CR94","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0165-0327(98)00025-1","volume":"49","author":"C Song","year":"1989","unstructured":"Song C, Lin A, Bonaccorso S, Heide C, Verkerk R, Kenis G, Bosmans E, Scharpe S et al (1989) The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. J Affect Disord 49(3):211\u2013219","journal-title":"J Affect Disord"},{"issue":"1","key":"1016_CR95","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2567.2010.03281.x","volume":"131","author":"EA Woodward","year":"2010","unstructured":"Woodward EA, Pr\u00eale CM, Nicholson SE, Kolesnik TB, Hart PH (2010) The anti-inflammatory effects of interleukin-4 are not mediated by suppressor of cytokine signalling-1 (SOCS1). Immunology 131(1):118\u2013127","journal-title":"Immunology"},{"issue":"4","key":"1016_CR96","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1378\/chest.117.4.1162","volume":"117","author":"SM Opal","year":"2000","unstructured":"Opal SM, DePalo VA (2000) Anti-inflammatory cytokines. Chest 117(4):1162\u20131172","journal-title":"Chest"},{"key":"1016_CR97","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3389\/fimmu.2013.00190","volume":"4","author":"DO Adeegbe","year":"2013","unstructured":"Adeegbe DO, Nishikawa H (2013) Natural and induced T regulatory cells in cancer. Front Immunol 4:190","journal-title":"Front Immunol"},{"issue":"1","key":"1016_CR98","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/jmcb\/mjr033","volume":"4","author":"DQ Tran","year":"2012","unstructured":"Tran DQ (2012) TGF-\u03b2: The sword, the wand, and the shield of FOXP3(+) regulatory T cells. J Mol Cell Biol 4(1):29\u201337","journal-title":"J Mol Cell Biol"},{"issue":"7","key":"1016_CR99","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","volume":"8","author":"DA Vignali","year":"2008","unstructured":"Vignali DA, Collison LW, Workman CJ (2008) How regulatory T cells work. Nat Rev Immunol 8(7):523\u2013532","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"1016_CR100","first-page":"510","volume":"11","author":"P Romagnani","year":"2000","unstructured":"Romagnani P, Annunziato F, Piccinni MP, Maggi E, Romagnani S (2000) Th1\/Th2 cells, their associated molecules and role in pathophysiology. Eur Cytokine Netw 11(3):510\u2013511","journal-title":"Eur Cytokine Netw"},{"issue":"6","key":"1016_CR101","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1189\/jlb.1209772","volume":"87","author":"S Chapoval","year":"2010","unstructured":"Chapoval S, Dasgupta P, Dorsey NJ, Keegan AD (2010) Regulation of the T helper cell type 2 (Th2)\/T regulatory cell (Treg) balance by IL-4 and STAT6. J Leukoc Biol 87(6):1011\u20131018","journal-title":"J Leukoc Biol"},{"issue":"3","key":"1016_CR102","first-page":"363","volume":"7","author":"DA Lawrence","year":"1996","unstructured":"Lawrence DA (1996) Transforming growth factor-beta: A general review. Eur Cytokine Netw 7(3):363\u2013374","journal-title":"Eur Cytokine Netw"},{"issue":"10","key":"1016_CR103","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/iub.239","volume":"61","author":"A Chaudhury","year":"2009","unstructured":"Chaudhury A, Howe PH (2009) The tale of transforming growth factor-beta (TGFbeta) signaling: A soign\u00e9 enigma. IUBMB Life 61(10):929\u2013939","journal-title":"IUBMB Life"},{"key":"1016_CR104","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683\u2013765","journal-title":"Annu Rev Immunol"},{"key":"1016_CR105","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1600-065X.2008.00706.x","volume":"226","author":"DM Mosser","year":"2008","unstructured":"Mosser DM, Zhang X (2008) Interleukin-10: New perspectives on an old cytokine. Immunol Rev 226:205\u2013218","journal-title":"Immunol Rev"},{"issue":"1\u20132","key":"1016_CR106","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0165-1781(01)00315-8","volume":"105","author":"S Bonaccorso","year":"2001","unstructured":"Bonaccorso S, Puzella A, Marino V, Pasquini M, Biondi M, Artini M, Almerighi C, Levrero M et al (2001) Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. Psychiatry Res 105(1\u20132):45\u201355","journal-title":"Psychiatry Res"},{"issue":"8","key":"1016_CR107","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0306-4530(01)00030-0","volume":"26","author":"L Capuron","year":"2001","unstructured":"Capuron L, Ravaud A, Gualde N, Bosmans E, Dantzer R, Maes M, Neveu PJ (2001) Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology 26(8):797\u2013808","journal-title":"Psychoneuroendocrinology"},{"issue":"1\u20133","key":"1016_CR108","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jad.2007.02.018","volume":"104","author":"YK Kim","year":"2007","unstructured":"Kim YK, Jung HG, Myint AM, Kim H, Park SH (2007) Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. J Affect Disord 104(1\u20133):91\u201395","journal-title":"J Affect Disord"},{"key":"1016_CR109","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jad.2015.08.036","volume":"187","author":"JG Fiedorowicz","year":"2015","unstructured":"Fiedorowicz JG, Prossin AR, Johnson CP, Christensen GE, Magnotta VA, Wemmie JA (2015) Peripheral inflammation during abnormal mood states in bipolar I disorder. J Affect Disord 187:172\u2013178","journal-title":"J Affect Disord"},{"issue":"3","key":"1016_CR110","first-page":"268","volume":"33","author":"M Kunz","year":"2011","unstructured":"Kunz M, Ceres\u00e9r KM, Goi PD, Fries GR, Teixeira AL, Fernandes BS, Belmonte-de-Abreu PS, Kauer-Sant\u2019Anna M et al (2011) Serum levels of IL-6, IL-10 and TNF-\u03b1 in patients with bipolar disorder and schizophrenia: Differences in pro- and anti-inflammatory balance. Rev Bras Psiquiatr 33(3):268\u2013274","journal-title":"Rev Bras Psiquiatr"},{"key":"1016_CR111","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jneuroim.2017.03.003","volume":"307","author":"CD Wiener","year":"2017","unstructured":"Wiener CD, Moreira FP, Cardoso TA, Mondin TC, da Silva Magalh\u00e3es PV, Kapczinski F, de Mattos Souza LD, da Silva RA et al (2017) Inflammatory cytokines and functional impairment in drug-free subjects with mood disorder. J Neuroimmunol 307:33\u201336","journal-title":"J Neuroimmunol"},{"issue":"4","key":"1016_CR112","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S0893-133X(98)00088-8","volume":"20","author":"M Maes","year":"1999","unstructured":"Maes M, Song C, Lin AH, Bonaccorso S, Kenis G, De Jongh R, Bosmans E, Scharp\u00e9 S (1999) Negative immunoregulatory effects of antidepressants: Inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology 20(4):370\u2013379","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"1016_CR113","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/00004714-200104000-00012","volume":"21","author":"M Kubera","year":"2001","unstructured":"Kubera M, Lin AH, Kenis G, Bosmans E, van Bockstaele D, Maes M (2001) Anti-inflammatory effects of antidepressants through suppression of the interferon-gamma\/interleukin-10 production ratio. J Clin Psychopharmacol 21(2):199\u2013206","journal-title":"J Clin Psychopharmacol"},{"key":"1016_CR114","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.bbi.2015.12.003","volume":"54","author":"L Grosse","year":"2016","unstructured":"Grosse L, Hoogenboezem T, Ambr\u00e9e O, Bellingrath S, J\u00f6rgens S, de Wit HJ, Wijkhuijs AM, Arolt V et al (2016) Deficiencies of the T and natural killer cell system in major depressive disorder: T regulatory cell defects are associated with inflammatory monocyte activation. Brain Behav Immun 54:38\u201344","journal-title":"Brain Behav Immun"},{"issue":"9","key":"1016_CR115","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s00213-015-3943-9","volume":"233","author":"L Grosse","year":"2016","unstructured":"Grosse L, Carvalho LA, Birkenhager TK, Hoogendijk WJ, Kushner SA, Drexhage HA, Bergink V (2016) Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy. Psychopharmacology 233(9):1679\u20131688","journal-title":"Psychopharmacology"},{"issue":"4","key":"1016_CR116","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1515\/REVNEURO.1993.4.4.407","volume":"4","author":"M Maes","year":"1993","unstructured":"Maes M (1993) A review on the acute phase response in major depression. Rev Neurosci 4(4):407\u2013416","journal-title":"Rev Neurosci"},{"issue":"7","key":"1016_CR117","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/j.1460-2075.1987.tb02450.x","volume":"6","author":"S Oliviero","year":"1987","unstructured":"Oliviero S, Morrone G, Cortese R (1987) The human haptoglobin gene: Transcriptional regulation during development and acute phase induction. EMBO J 6(7):1905\u20131912","journal-title":"EMBO J"},{"issue":"2","key":"1016_CR118","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1365-2567.2004.02071.x","volume":"114","author":"MS Arredouani","year":"2005","unstructured":"Arredouani MS, Kasran A, Vanoirbeek JA, Berger FG, Baumann H, Ceuppens JL (2005) Haptoglobin dampens endotoxin-induced inflammatory effects both in vitro and in vivo. Immunology 114(2):263\u2013271","journal-title":"Immunology"},{"issue":"7","key":"1016_CR119","doi-asserted-by":"publisher","first-page":"e85375","DOI":"10.1172\/jci.insight.85375","volume":"1","author":"H Yang","year":"2016","unstructured":"Yang H, Wang H, Levine YA, Gunasekaran MK, Wang Y, Addorisio M, Zhu S, Li W et al (2016) Identification of CD163 as an anti-inflammatory receptor for HMGB1-haptoglobin complexes. JCI Insight 1(7):e85375","journal-title":"JCI Insight"},{"issue":"4","key":"1016_CR120","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nri1594","volume":"5","author":"MT Lotze","year":"2005","unstructured":"Lotze MT, Tracey KJ (2005) High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat Rev Immunol 5(4):331\u2013342","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"1016_CR121","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.4049\/jimmunol.1103623","volume":"189","author":"T Lin","year":"2012","unstructured":"Lin T, Sammy F, Yang H, Thundivalappil S, Hellman J, Tracey KJ, Warren HS (2012) Identification of hemopexin as an anti-inflammatory factor that inhibits synergy of hemoglobin with HMGB1 in sterile and infectious inflammation. J Immunol 189(4):2017\u20132022","journal-title":"J Immunol"},{"key":"1016_CR122","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3389\/fphys.2015.00187","volume":"6","author":"A Smith","year":"2015","unstructured":"Smith A, McCulloh RJ (2015) Hemopexin and haptoglobin: Allies against heme toxicity from hemoglobin not contenders. Front Physiol 6:187","journal-title":"Front Physiol"},{"issue":"1","key":"1016_CR123","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1161\/01.RES.0000109414.78907.F9","volume":"94","author":"P Philippidis","year":"2004","unstructured":"Philippidis P, Mason JC, Evans BJ, Nadra I, Taylor KM, Haskard DO, Landis RC (2004) Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: Antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ Res 94(1):119\u2013126","journal-title":"Circ Res"},{"issue":"2","key":"1016_CR124","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0021-9150(99)00079-9","volume":"145","author":"J Delanghe","year":"1999","unstructured":"Delanghe J, Langlois M, Duprez D, De Buyzere M, Clement D (1999) Haptoglobin polymorphism and peripheral arterial occlusive disease. Atherosclerosis 145(2):287\u2013292","journal-title":"Atherosclerosis"},{"issue":"4","key":"1016_CR125","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.bbrc.2006.12.092","volume":"353","author":"SA Saeed","year":"2007","unstructured":"Saeed SA, Ahmad N, Ahmed S (2007) Dual inhibition of cyclooxygenase and lipoxygenase by human haptoglobin: Its polymorphism and relation to hemoglobin binding. Biochem Biophys Res Commun 353(4):915\u2013920","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"1016_CR126","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1096\/fj.02-0019fje","volume":"16","author":"DP Kleijn de","year":"2002","unstructured":"de Kleijn DP, Smeets MB, Kemmeren PP, Lim SK, Van Middelaar BJ, Velema E, Schoneveld A, Pasterkamp G et al (2002) Acute-phase protein haptoglobin is a cell migration factor involved in arterial restructuring. FASEB J 16(9):1123\u20131125","journal-title":"FASEB J"},{"issue":"8","key":"1016_CR127","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.trstmh.2008.04.010","volume":"102","author":"IK Quaye","year":"2008","unstructured":"Quaye IK (2008) Haptoglobin, inflammation and disease. Trans R Soc Trop Med Hyg 102(8):735\u2013742","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"1016_CR128","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1176\/ajp.151.1.112","volume":"151","author":"M Maes","year":"1994","unstructured":"Maes M, Delanghe J, Scharp\u00e9 S, Meltzer HY, Cosyns P, Suy E, Bosmans E (1994) Haptoglobin phenotypes and gene frequencies in unipolar major depression. Am J Psychiatry 151(1):112\u2013116","journal-title":"Am J Psychiatry"},{"issue":"1","key":"1016_CR129","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.atherosclerosis.2006.04.032","volume":"191","author":"J Guetta","year":"2007","unstructured":"Guetta J, Strauss M, Levy NS, Fahoum L, Levy AP (2007) Haptoglobin genotype modulates the balance of Th1\/Th2 cytokines produced by macrophages exposed to free hemoglobin. Atherosclerosis 191(1):48\u201353","journal-title":"Atherosclerosis"},{"issue":"1","key":"1016_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-1781(96)02915-0","volume":"66","author":"M Maes","year":"1997","unstructured":"Maes M, Delange J, Ranjan R, Meltzer HY, Desnyder R, Cooremans W, Scharp\u00e9 S (1997) Acute phase proteins in schizophrenia, mania and major depression: Modulation by psychotropic drugs. Psychiatry Res 66(1):1\u201311","journal-title":"Psychiatry Res"},{"issue":"11","key":"1016_CR131","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.4049\/jimmunol.1203076","volume":"191","author":"S Rolla","year":"2013","unstructured":"Rolla S, Ingoglia G, Bardina V, Silengo L, Altruda F, Novelli F, Tolosano E (2013) Acute-phase protein hemopexin is a negative regulator of Th17 response and experimental autoimmune encephalomyelitis development. J Immunol 191(11):5451\u20135459","journal-title":"J Immunol"},{"issue":"1","key":"1016_CR132","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1359-6101(02)00054-0","volume":"14","author":"T Hochepied","year":"2003","unstructured":"Hochepied T, Berger FG, Baumann H, Libert C (2003) Alpha(1)-acid glycoprotein: An acute phase protein with inflammatory and immunomodulating properties. Cytokine Growth Factor Rev 14(1):25\u201334","journal-title":"Cytokine Growth Factor Rev"},{"issue":"37","key":"1016_CR133","doi-asserted-by":"publisher","first-page":"15007","DOI":"10.1073\/pnas.1309648110","volume":"110","author":"D Jonigk","year":"2013","unstructured":"Jonigk D, Al-Omari M, Maegel L, M\u00fcller M, Izykowski N, Hong J, Hong K, Kim SH et al (2013) Anti-inflammatory and immunomodulatory properties of \u03b11-antitrypsin without inhibition of elastase. Proc Natl Acad Sci U S A 110(37):15007\u201315012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1016_CR134","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00005-012-0162-5","volume":"60","author":"DA Bergin","year":"2012","unstructured":"Bergin DA, Hurley K, McElvaney NG, Reeves EP (2012) Alpha-1 antitrypsin: A potent anti-inflammatory and potential novel therapeutic agent. Arch Immunol Ther Exp 60(2):81\u201397","journal-title":"Arch Immunol Ther Exp"},{"issue":"9","key":"1016_CR135","doi-asserted-by":"publisher","first-page":"6465","DOI":"10.1074\/jbc.M112.418970","volume":"288","author":"AL Chapman","year":"2013","unstructured":"Chapman AL, Mocatta TJ, Shiva S, Seidel A, Chen B, Khalilova I, Paumann-Page ME, Jameson GN et al (2013) Ceruloplasmin is an endogenous inhibitor of myeloperoxidase. J Biol Chem 288(9):6465\u20136477","journal-title":"J Biol Chem"},{"issue":"2","key":"1016_CR136","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/gutjnl-2011-300694","volume":"62","author":"B Bakhautdin","year":"2013","unstructured":"Bakhautdin B, Febbraio M, Goksoy E, de la Motte CA, Gulen MF, Childers EP, Hazen SL, Li X et al (2013) Protective role of macrophage-derived ceruloplasmin in inflammatory bowel disease. Gut 62(2):209\u2013219","journal-title":"Gut"},{"issue":"2","key":"1016_CR137","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.neubiorev.2011.12.005","volume":"36","author":"B Leonard","year":"2012","unstructured":"Leonard B, Maes M (2012) Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev 36(2):764\u2013785","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"1016_CR138","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1007\/s12035-017-0545-z","volume":"55","author":"Cinthya Gomes","year":"2017","unstructured":"Gomes C, Martinho FC, Barbosa DS, Antunes LS, P\u00f3voa HCC, Baltus THL, Morelli NR, Vargas HO et al (2017) Increased root canal endotoxin levels are associated with chronic apical periodontitis, increased oxidative and Nitrosative stress, major depression, severity of depression, and a lowered quality of life. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-017-0545-z","journal-title":"Molecular Neurobiology"},{"issue":"3","key":"1016_CR139","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.pnpbp.2010.12.017","volume":"35","author":"M Maes","year":"2011","unstructured":"Maes M, Leonard BE, Myint AM, Kubera M, Verkerk R (2011) The new '5-HT' hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuro-Psychopharmacol Biol Psychiatry 35(3):702\u2013721","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"2","key":"1016_CR140","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/pcn.12625","volume":"72","author":"Chutima Roomruangwong","year":"2018","unstructured":"Roomruangwong C, Barbosa DS, de Farias CC, Matsumoto AK, Baltus THL, Morelli NR, Kanchanatawan B, Duleu S et al (2017) Natural regulatory IgM-mediated autoimmune responses directed against malondialdehyde regulate oxidative and nitrosative pathways and coupled with IgM responses to nitroso-adducts attenuate depressive and physiosomatic symptoms at the end of term pregnancy. Psychiatry Clin Neurosci. https:\/\/doi.org\/10.1111\/pcn.12625","journal-title":"Psychiatry and Clinical Neurosciences"},{"issue":"1\u20133","key":"1016_CR141","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jad.2011.08.023","volume":"135","author":"M Maes","year":"2011","unstructured":"Maes M, Mihaylova I, Kubera M, Leunis JC, Geffard M (2011) IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: New pathways that underpin the inflammatory and neuroprogressive pathophysiology. J Affect Disord 135(1\u20133):414\u2013418","journal-title":"J Affect Disord"},{"issue":"4","key":"1016_CR142","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/sj.mp.4000721","volume":"5","author":"SM Antelman","year":"2000","unstructured":"Antelman SM, Levine J, Gershon S (2000) Time-dependent sensitization: The odyssey of a scientific heresy from the laboratory to the door of the clinic. Mol Psychiatry 5(4):350\u2013356","journal-title":"Mol Psychiatry"},{"issue":"11","key":"1016_CR143","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/0006-3223(94)90021-3","volume":"35","author":"IR Bell","year":"1994","unstructured":"Bell IR, Schwartz GE, Amend D, Peterson JM, Stini WA (1994) Sensitization to early life stress and response to chemical odors in older adults. Biol Psychiatry 35(11):857\u2013863","journal-title":"Biol Psychiatry"},{"issue":"1\u20133","key":"1016_CR144","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0165-0327(00)00156-7","volume":"63","author":"M Maes","year":"2001","unstructured":"Maes M, Ombelet W, De Jongh R, Kenis G, Bosmans E (2001) The inflammatory response following delivery is amplified in women who previously suffered from major depression, suggesting that major depression is accompanied by a sensitization of the inflammatory response system. J Affect Disord 63(1\u20133):85\u201392","journal-title":"J Affect Disord"},{"issue":"3","key":"1016_CR145","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jad.2011.11.016","volume":"136","author":"M Maes","year":"2012","unstructured":"Maes M, Ringel K, Kubera M, Berk M, Rybakowski J (2012) Increased autoimmune activity against 5-HT: A key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression. J Affect Disord 136(3):386\u2013392","journal-title":"J Affect Disord"},{"issue":"2","key":"1016_CR146","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.pnpbp.2010.01.002","volume":"34","author":"C Celik","year":"2010","unstructured":"Celik C, Erdem M, Cayci T, Ozdemir B, Ozgur Akgul E, Kurt YG, Yaman H, Isintas M et al (2010) The association between serum levels of neopterin and number of depressive episodes of major depression. Prog Neuro-Psychopharmacol Biol Psychiatry 34(2):372\u2013375","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"4","key":"1016_CR147","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/0278-5846(94)90079-5","volume":"18","author":"M Maes","year":"1994","unstructured":"Maes M, Meltzer HY, Stevens W, Calabrese J, Cosyns P (1994) Natural killer cell activity in major depression: Relation to circulating natural killer cells, cellular indices of the immune response, and depressive phenomenology. Prog Neuro-Psychopharmacol Biol Psychiatry 18(4):717\u2013730","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"1","key":"1016_CR148","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0162-3109(96)00111-7","volume":"34","author":"Z Xia","year":"1996","unstructured":"Xia Z, DePierre JW, N\u00e4ssberger L (1996) Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology 34(1):27\u201337","journal-title":"Immunopharmacology"},{"issue":"1","key":"1016_CR149","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.2042-7158.1996.tb05889.x","volume":"48","author":"Z Xia","year":"1996","unstructured":"Xia Z, Depierre JW, N\u00e4ssberger L (1996) The tricyclic antidepressants clomipramine and citalopram induce apoptosis in cultured human lymphocytes. J Pharm Pharmacol 48(1):115\u2013116","journal-title":"J Pharm Pharmacol"},{"key":"1016_CR150","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.taap.2017.03.002","volume":"322","author":"W Qiu","year":"2017","unstructured":"Qiu W, Wu M, Liu S, Chen B, Pan C, Yang M, Wang KJ (2017) Suppressive immunoregulatory effects of three antidepressants via inhibition of the nuclear factor-\u03baB activation assessed using primary macrophages of carp (Cyprinus carpio). Toxicol Appl Pharmacol 322:1\u20138","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"1016_CR151","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.pnpbp.2010.06.014","volume":"35","author":"M Maes","year":"2011","unstructured":"Maes M (2011) Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Prog Neuro-Psychopharmacol Biol Psychiatry 35(3):664\u2013675","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"3","key":"1016_CR152","first-page":"207","volume":"25","author":"M Kubera","year":"2004","unstructured":"Kubera M, Basta-Kaim A, Wr\u00f3bel A, Maes M, Dudek D (2004) Increased mitogen-induced lymphocyte proliferation in treatment resistant depression: A preliminary study. Neuro Endocrinol Lett 25(3):207\u2013210","journal-title":"Neuro Endocrinol Lett"},{"issue":"6","key":"1016_CR153","first-page":"547","volume":"51","author":"M Kubera","year":"1999","unstructured":"Kubera M, Van Bockstaele D, Maes M (1999) Leukocyte subsets in treatment-resistant major depression. Pol J Pharmacol 51(6):547\u2013549","journal-title":"Pol J Pharmacol"},{"key":"1016_CR154","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1741-7015-11-64","volume":"11","author":"G Morris","year":"2013","unstructured":"Morris G, Anderson G, Galecki P, Berk M, Maes M (2013) A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) and sickness behavior. BMC Med 11:64","journal-title":"BMC Med"},{"key":"1016_CR155","doi-asserted-by":"publisher","DOI":"10.1201\/9781420048193.ch3","volume-title":"Cytokines","author":"An Van Gastel","year":"1998","unstructured":"Maes M, Song C, Lin A, DeJong R, Van Gastel A, Kenis G, Bosmans E, DeMeester I, Neels H, Janca A, Scharpe S, Smith RS (1998) Immune and clinical correlates of psychological stress-induced production of interferon-\u03b3 and interleukin-10 in humans. Cytokines, Stress and Immunity; Editors: Plotnikoff NP, Faith RE, Murgo AJ, Good RA, pp 39\u201350. https:\/\/doi.org\/10.1201\/9781420048193.ch3"},{"issue":"9","key":"1016_CR156","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/icb.2017.53","volume":"95","author":"PM Guimar\u00e3es","year":"2017","unstructured":"Guimar\u00e3es PM, Scavuzzi BM, Stadtlober NP, Franchi Santos LFDR, Lozovoy MAB, Iriyoda TMV, Costa NT, Reiche EMV et al (2017) Cytokines in systemic lupus erythematosus: Far beyond Th1\/Th2 dualism lupus: Cytokine profiles. Immunol Cell Biol 95(9):824\u2013831","journal-title":"Immunol Cell Biol"},{"key":"1016_CR157","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.neubiorev.2014.05.007","volume":"45","author":"S Moylan","year":"2014","unstructured":"Moylan S, Berk M, Dean OM, Samuni Y, Williams LJ, O'Neil A, Hayley AC, Pasco JA et al (2014) Oxidative & nitrosative stress in depression: Why so much stress? Neurosci Biobehav Rev 45:46\u201362","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"1016_CR158","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.pnpbp.2010.05.004","volume":"35","author":"M Maes","year":"2011","unstructured":"Maes M, Galecki P, Chang YS, Berk M (2011) A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuro-Psychopharmacol Biol Psychiatry 35(3):676\u2013692","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"10","key":"1016_CR159","doi-asserted-by":"publisher","first-page":"e0138904","DOI":"10.1371\/journal.pone.0138904","volume":"10","author":"T Liu","year":"2015","unstructured":"Liu T, Zhong S, Liao X, Chen J, He T, Lai S, Jia Y (2015) A meta-analysis of oxidative stress markers in depression. PLoS One 10(10):e0138904","journal-title":"PLoS One"},{"key":"1016_CR160","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.neubiorev.2017.07.017","volume":"84","author":"G Morris","year":"2018","unstructured":"Morris G, Walder K, Carvalho AF, Tye SJ, Lucas K, Berk M, Maes M (2018) The role of hypernitrosylation in the pathogenesis and pathophysiology of neuroprogressive diseases. Neurosci Biobehav Rev 84:453\u2013469","journal-title":"Neurosci Biobehav Rev"},{"issue":"6","key":"1016_CR161","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.1007\/s12035-016-9975-2","volume":"54","author":"G Morris","year":"2017","unstructured":"Morris G, Berk M, Klein H, Walder K, Galecki P, Maes M (2017) Nitrosative stress, Hypernitrosylation, and autoimmune responses to Nitrosylated proteins: New pathways in Neuroprogressive disorders including depression and chronic fatigue syndrome. Mol Neurobiol 54(6):4271\u20134291","journal-title":"Mol Neurobiol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-018-1016-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1016-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1016-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T17:11:27Z","timestamp":1720199487000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-018-1016-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,2]]},"references-count":161,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1016"],"URL":"https:\/\/doi.org\/10.1007\/s12035-018-1016-x","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,2]]},"assertion":[{"value":"12 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}